{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:21:52Z","timestamp":1795065712270,"version":"4.10.2"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Aspartame (APM) is a widely consumed artificial sweetener that has recently been implicated in the pathogenesis of metabolic disorders. However, the molecular mechanisms linking APM to metabolic-associated fatty liver disease (MAFLD) remain poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This study employed a comprehensive analytical strategy, integrating network toxicology, molecular docking, molecular dynamics simulations, machine learning, bulk RNA sequencing and single-cell transcriptomics, Mendelian randomization, and histological validation, to systematically investigate APM-associated molecular targets and their potential role in MAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The ADMETlab3.0 prediction indicated that APM exhibits strong hepatotoxic potential. Network toxicology analysis identified 80 overlapping genes, among which aminopeptidase (ANPEP) demonstrated the lowest binding energy to APM (\u22128.2\u00a0kcal\/mol). Molecular dynamics simulations further confirmed the stability of this interaction. Bulk RNA-seq data revealed that ANPEP was significantly upregulated in MAFLD liver tissues (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and achieved robust diagnostic performance (AUC\u00a0=\u00a00.84, 95% CI: 0.69\u20131.00,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). In mouse models, ANPEP expression was significantly elevated (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.005). Mendelian randomization analysis indicated that elevated ANPEP levels were significantly associated with a higher risk of MAFLD (OR\u00a0=\u00a01.069, 95% CI: 1.017\u20131.124,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.008). Single-cell sequencing and immunofluorescence analyses consistently confirmed that ANPEP was predominantly localized in CD68\u207a myeloid cells and was markedly upregulated as early as the fibrotic initiation stage of MAFLD (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ANPEP was identified as a potential target that links aspartame exposure to MAFLD and was further associated with inflammation, lipid dysregulation, and fibrosis. These findings suggest that aspartame may not represent a safe strategy for weight management and could increase the risk of liver injury and MAFLD progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004068","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:01:20Z","timestamp":1763402480000},"page":"6038-6055","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["ANPEP as a potential mediator linking aspartame exposure to MAFLD: insights from network toxicology and multi-omics analyses"],"prefix":"10.1097","volume":"112","author":[{"given":"Long","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengliang","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuan","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandan","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6760-2805","authenticated-orcid":false,"given":"Qiujing","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing, China"},{"name":"Department of Infectious Diseases, Peking University International Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"R1-20260417","doi-asserted-by":"crossref","first-page":"638\u201351","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R2-20260417","doi-asserted-by":"crossref","first-page":"1082\u201397","DOI":"10.1007\/s12072-023-10568-z","article-title":"Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes","volume":"17","author":"Vaz","year":"2023","journal-title":"Hepatol Int"},{"key":"R3-20260417","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1038\/s41598-025-91312-5","article-title":"Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021","volume":"15","author":"Guo","year":"2025","journal-title":"Sci Rep"},{"key":"R4-20260417","doi-asserted-by":"crossref","first-page":"863\u201376","DOI":"10.1002\/cac2.12454","article-title":"Differential risk of 23 site-specific incident cancers and cancer-related mortality among patients with metabolic dysfunction-associated fatty liver disease: a population-based cohort study with 9.7 million korean subjects","volume":"43","author":"Chung","year":"2023","journal-title":"Cancer Commun"},{"key":"R5-20260417","doi-asserted-by":"crossref","first-page":"108844","DOI":"10.1016\/j.pharmthera.2025.108844","article-title":"Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: pathogenesis and therapeutic targets","volume":"269","author":"Chu","year":"2025","journal-title":"Pharmacol Ther"},{"key":"R6-20260417","first-page":"16\u201336","article-title":"Taiwan association for the study of the liver-taiwan society of cardiology taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases","volume":"30","author":"Cheng","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"R7-20260417","doi-asserted-by":"crossref","first-page":"155607","DOI":"10.1016\/j.metabol.2023.155607","article-title":"Hepatic insulin receptor: new views on the mechanisms of liver disease","volume":"145","author":"Lee","year":"2023","journal-title":"Metabolism"},{"key":"R8-20260417","doi-asserted-by":"crossref","first-page":"957245","DOI":"10.3389\/fendo.2022.957245","article-title":"High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation","volume":"13","author":"Decoin","year":"2022","journal-title":"Front Endocrinol"},{"key":"R9-20260417","doi-asserted-by":"crossref","first-page":"1291501","DOI":"10.3389\/fmed.2024.1291501","article-title":"Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies","volume":"11","author":"Habibullah","year":"2024","journal-title":"Front Med"},{"key":"R10-20260417","doi-asserted-by":"crossref","first-page":"102973","DOI":"10.1016\/j.dsx.2024.102973","article-title":"Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: a cross-sectional study","volume":"18","author":"He","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"R11-20260417","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3390\/nu13061957","article-title":"Aspartame-true or false? Narrative review of safety analysis of general use in products","volume":"13","author":"Czarnecka","year":"2021","journal-title":"Nutrients"},{"key":"R12-20260417","doi-asserted-by":"crossref","first-page":"731\u201354","DOI":"10.2337\/dci19-0014","article-title":"Nutrition therapy for adults with diabetes or prediabetes: a consensus report","volume":"42","author":"Evert","year":"2019","journal-title":"Diabetes Care"},{"key":"R13-20260417","doi-asserted-by":"crossref","first-page":"796\u2013804","DOI":"10.1038\/s41430-018-0170-6","article-title":"Glycemic impact of non-nutritive sweeteners: a systematic review and meta-analysis of randomized controlled trials","volume":"72","author":"Nichol","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"R14-20260417","first-page":"7\u201315","article-title":"The debate over neurotransmitter interaction in aspartame usage","volume":"56","author":"Choudhary","year":"2018","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"R15-20260417","doi-asserted-by":"crossref","first-page":"e071204","DOI":"10.1136\/bmj-2022-071204","article-title":"Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-sant\u00e9 cohort","volume":"378","author":"Debras","year":"2022","journal-title":"Bmj"},{"key":"R16-20260417","doi-asserted-by":"crossref","first-page":"517\u201323","DOI":"10.1016\/j.physbeh.2016.04.047","article-title":"Low-calorie sweetener use and energy balance: results from experimental studies in animals, and large-scale prospective studies in humans","volume":"164","author":"Fowler","year":"2016","journal-title":"Physiol Behav"},{"key":"R17-20260417","doi-asserted-by":"crossref","first-page":"109\u201315","DOI":"10.1016\/j.fct.2013.07.040","article-title":"Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues","volume":"60","author":"Marinovich","year":"2013","journal-title":"Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc"},{"key":"R18-20260417","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11894-017-0602-9","article-title":"The association between artificial sweeteners and obesity","volume":"19","author":"Pearlman","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"R19-20260417","doi-asserted-by":"crossref","first-page":"181\u201386","DOI":"10.1038\/nature13793","article-title":"Artificial sweeteners induce glucose intolerance by altering the gut microbiota","volume":"514","author":"Suez","year":"2014","journal-title":"Nature"},{"key":"R20-20260417","doi-asserted-by":"crossref","first-page":"431\u201341","DOI":"10.1016\/j.tem.2013.05.005","article-title":"Artificial sweeteners produce the counterintuitive effect of inducing metabolic derangements","volume":"24","author":"Swithers","year":"2013","journal-title":"Trends Endocrinol Metab TEM"},{"key":"R21-20260417","first-page":"1\u201317","article-title":"Not so sweet revenge: unanticipated consequences of high-intensity sweeteners","volume":"38","author":"Swithers","year":"2015","journal-title":"Behav Anal"},{"key":"R22-20260417","first-page":"106\u201310","article-title":"Not-so-healthy sugar substitutes?","volume":"9","author":"Swithers","year":"2016","journal-title":"Curr Opin Behav Sci"},{"key":"R23-20260417","doi-asserted-by":"crossref","first-page":"598340","DOI":"10.3389\/fnut.2020.598340","article-title":"The impact of artificial sweeteners on body weight control and glucose homeostasis","volume":"7","author":"Pang","year":"2020","journal-title":"Front Nutr"},{"key":"R24-20260417","doi-asserted-by":"crossref","first-page":"701\u201307","DOI":"10.1016\/j.redox.2017.01.019","article-title":"Chronic aspartame intake causes changes in the trans-sulphuration pathway, glutathione depletion and liver damage in mice","volume":"11","author":"Finamor","year":"2017","journal-title":"Redox Biol"},{"key":"R25-20260417","first-page":"299\u2013305","article-title":"Long-term effect of aspartame on the liver antioxidant status and histopathology in Wistar albino rats","volume":"4","author":"Ashok","year":"2014","journal-title":"Biomed Prev Nutr"},{"key":"R26-20260417","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/jox15040114","article-title":"Aspartame and human health: a mini-review of carcinogenic and systemic effects","volume":"15","author":"Doueihy","year":"2025","journal-title":"J Xenobiotics"},{"key":"R27-20260417","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/biology10020082","article-title":"Long-term aspartame administration leads to fibrosis, inflammasome activation, and gluconeogenesis impairment in the liver of mice","volume":"10","author":"Finamor","year":"2021","journal-title":"Biology"},{"key":"R28-20260417","first-page":"100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R29-20260417","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"Updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R30-20260417","doi-asserted-by":"crossref","first-page":"1.30.1\u20131.30.33","DOI":"10.1002\/cpbi.5","article-title":"The GeneCards suite: from gene data mining to disease genome sequence analyses","volume":"54","author":"Stelzer","year":"2016","journal-title":"Curr Protoc Bioinforma"},{"key":"R31-20260417","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R32-20260417","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innov Camb Mass"},{"key":"R33-20260417","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51(D1)","author":"Kim","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"R34-20260417","doi-asserted-by":"crossref","first-page":"3891\u201398","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J Chem Inf Model"},{"key":"R35-20260417","doi-asserted-by":"crossref","first-page":"e13707","DOI":"10.1111\/jfbc.13707","article-title":"Study on the mechanism of active components of liupao tea on 3CLpro based on HPLC-DAD fingerprint and molecular docking technique","volume":"45","author":"Ni","year":"2021","journal-title":"J Food Biochem"},{"key":"R36-20260417","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00894-019-4232-z","article-title":"Enhanced GROMACS: toward a better numerical simulation framework","volume":"25","author":"Rakhshani","year":"2019","journal-title":"J Mol Model"},{"key":"R37-20260417","doi-asserted-by":"crossref","first-page":"eaba4448","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"key":"R38-20260417","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1743-7075-10-44","article-title":"Prediabetic changes in gene expression induced by aspartame and monosodium glutamate in Trans fat-fed C57Bl\/6 J mice","volume":"10","author":"Collison","year":"2013","journal-title":"Nutr Metab"},{"key":"R39-20260417","doi-asserted-by":"crossref","first-page":"461\u201368","DOI":"10.1038\/s41588-024-02044-7","article-title":"A scalable variational inference approach for increased mixed-model association power","volume":"57","author":"Loya","year":"2025","journal-title":"Nat Genet"},{"key":"R40-20260417","doi-asserted-by":"crossref","first-page":"100744","DOI":"10.1016\/j.jhepr.2023.100744","article-title":"Genetic variants in HFE are associated with non-alcoholic fatty liver disease in lean individuals","volume":"5","author":"Sun","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"R41-20260417","doi-asserted-by":"crossref","first-page":"100877","DOI":"10.1016\/j.jhepr.2023.100877","article-title":"Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Chan","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"key":"R42-20260417","doi-asserted-by":"crossref","first-page":"153\u201367","DOI":"10.1136\/gutjnl-2021-325915","article-title":"Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients","volume":"72","author":"Zhang","year":"2023","journal-title":"Gut"},{"key":"R43-20260417","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s12032-022-01795-9","article-title":"Investigation of the effect of meclofenamic acid on the proteome of LNCaP cells reveals changes in alternative polyadenylation and splicing machinery","volume":"39","author":"Saglam","year":"2022","journal-title":"Med Oncol"},{"key":"R44-20260417","first-page":"9","article-title":"Unlocking the potential of RARRES1: a pan-cancer analysis for prognosis, diagnosis, tumor immunity and drug sensitivity","volume":"31","author":"Korak","year":"2024","journal-title":"J Biol Res Thessalon"},{"key":"R45-20260417","doi-asserted-by":"crossref","first-page":"107282","DOI":"10.1016\/j.phrs.2024.107282","article-title":"Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions \u2013 a review","volume":"206","author":"Zhou","year":"2024","journal-title":"Pharmacol Res"},{"key":"R46-20260417","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40001-015-0090-z","article-title":"Role of receptor for advanced glycation end products (RAGE) in liver disease","volume":"20","author":"Yamagishi","year":"2015","journal-title":"Eur J Med Res"},{"key":"R47-20260417","doi-asserted-by":"crossref","first-page":"361\u201371","DOI":"10.1016\/j.molmed.2008.06.003","article-title":"The moonlighting enzyme CD13: old and new functions to target","volume":"14","author":"Mina-Osorio","year":"2008","journal-title":"Trends Mol Med"},{"key":"R48-20260417","doi-asserted-by":"crossref","first-page":"e8793","DOI":"10.15252\/msb.20188793","article-title":"Plasma proteome profiling discovers novel proteins associated with non-alcoholic fatty liver disease","volume":"15","author":"Niu","year":"2019","journal-title":"Mol Syst Biol"},{"key":"R49-20260417","doi-asserted-by":"crossref","first-page":"130\u201344","DOI":"10.1016\/j.virol.2004.11.009","article-title":"Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection","volume":"332","author":"Bi\u00e8che","year":"2005","journal-title":"Virology"},{"key":"R50-20260417","doi-asserted-by":"crossref","first-page":"241\u201351","DOI":"10.1016\/j.athoracsur.2023.09.036","article-title":"ANPEP\/CD13 expression as a marker of lymphovascular invasion and survival in esophageal adenocarcinoma","volume":"118","author":"Goltsov","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"R51-20260417","doi-asserted-by":"crossref","first-page":"53\u201367","DOI":"10.1053\/j.gastro.2024.08.032","article-title":"Unveiling cancer-related metaplastic cells in both helicobacter pylori infection and autoimmune gastritis","volume":"168","author":"Hoft","year":"2025","journal-title":"Gastroenterology"},{"key":"R52-20260417","doi-asserted-by":"crossref","first-page":"161\u201371","DOI":"10.1038\/s41390-022-02431-y","article-title":"Proteomic profiling of urinary small extracellular vesicles in children with pneumonia: a pilot study","volume":"94","author":"Cheng","year":"2023","journal-title":"Pediatr Res"},{"key":"R53-20260417","doi-asserted-by":"crossref","first-page":"14639\u201349","DOI":"10.1021\/acs.analchem.4c03298","article-title":"A nanofluorescent probe for evaluating the fluctuation of aminopeptidase n in nonalcoholic fatty liver disease and hepatic fibrosis","volume":"96","author":"Sun","year":"2024","journal-title":"Anal Chem"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:00:31Z","timestamp":1776423631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000004068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004068","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"2025-06-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}